Good Start Genetics, UnitedHealthcare Pen Agreement for Genetic Screening Services

Oct 14, 2015 | staff reporter

NEW YORK (GenomeWeb) – Good Start Genetics has become an in-network laboratory partner for a variety of genetic screening tests under a national relationship with UnitedHealthcare, the company said today.

The agreement becomes effective Oct. 15. "We believe Good Start Genetics has set the new standard of care in genetic screening for inherited diseases, and our new relationship with UnitedHealthcare gives tens of millions more Americans access to these important carrier screening tests," Don Hardison, president and chief executive officer of Good Start Genetics, said in a statement.

Good Start Genetics offers a genetic carrier screening service called GeneVu and a preimplantation genetic screening test, EmbryVu, which both use next-generation sequencing technology. UnitedHealthcare covers more than 43 million lives.

Filed under

Reproductive Health

Molecular Diagnostics

hereditary disease

carrier screening

Next-Generation Sequencing

Good Start Genetics

UnitedHealthCare

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.